Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 39 news outlets
blogs: 8 blogs
twitter: 343 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page
video: 1 YouTube creator
bluesky: 3 Bluesky users
podcasts: 4 podcasts

Readers on

mendeley: 213 Mendeley

So far, Altmetric has seen 378 X posts from 343 X users, with an upper bound of 1,751,622 followers.

https://t.co/iNxCiR4YNl

RT @daperezm: Resultado del ensayo SYMBAD sobre eficacia Mirtazapina en la agitación de pacientes con demencia: sin eficacia y con tendenci…

Foundation trainee clinical presentations - today @edwardjbwright on trazodone, useful zero ACB agent vs mirtazipine in dementia https://t.co/TeG5RDBWVM https://t.co/Ph1by0yvjX

Important NHS funded study

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 374 additional X posts.